Literature DB >> 27351929

HIV infection among persons who inject drugs: ending old epidemics and addressing new outbreaks.

Françoise Cazein1, Josiane Pillonel, Francis Barin, Marie Jauffret-Roustide.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27351929     DOI： 10.1097/QAD.0000000000001115

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  4 in total

1.  HIV infection among persons who inject drugs: ending old epidemics and addressing new outbreaks: authors' reply.

Authors:  Don C Des Jarlais; Patrizia Carrieri
Journal:  AIDS       Date:  2016-07-17       Impact factor: 4.177

2.  Innovative Approach for Enhancing Testing of HIV, Hepatitis B, and Hepatitis C in the General Population: Protocol for an Acceptability and Feasibility Study (BaroTest 2016).

Authors:  Nathalie Lydié; Leila Saboni; Arnaud Gautier; Cécile Brouard; Stéphane Chevaliez; Francis Barin; Christine Larsen; Florence Lot; Delphine Rahib
Journal:  JMIR Res Protoc       Date:  2018-10-12

3.  Impact of drug consumption rooms on risk practices and access to care in people who inject drugs in France: the COSINUS prospective cohort study protocol.

Authors:  Marc Auriacombe; Perrine Roux; Laurence Lalanne; Marie Jauffret-Roustide; Laélia Briand Madrid; Sébastien Kirchherr; Charlotte Kervran; Carole Chauvin; Marie Gutowski; Cécile Denis; Maria Patrizia Carrieri
Journal:  BMJ Open       Date:  2019-02-21       Impact factor: 2.692

4.  Acceptability of on-site rapid HIV/HBV/HCV testing and HBV vaccination among three at-risk populations in distinct community-healthcare outreach centres: the ANRS-SHS 154 CUBE study.

Authors:  Ruxandra Calin; Véronique Massari; Gilles Pialoux; Nelly Reydellet; Eve Plenel; Carole Chauvin; Marie Jauffret-Roustide; Nesrine Day; Georges Kreplak; Anaenza Freire Maresca; Nicolas Derche; Sandra Louis; Stanislas Pol; Véronique Doré; Christine Rouzioux; Pierre Chauvin
Journal:  BMC Infect Dis       Date:  2020-11-16       Impact factor: 3.090
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.